Neoplasms Metastasis Completed Phase 2 Trials for Cetuximab (DB00002)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00444678Cetuximab, Capecitabine and Oxaliplatin in Patients With Epidermal Growth Factor Receptor (EGFr) Expressing Metastatic Colorectal CancerTreatment
NCT00130689Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric CancerTreatment
NCT00125034Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC)Treatment